EdgarLookup

Invesco DB Commodity Index Tracking Fund — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Invesco DB Commodity Index Tracking Fund filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
7.5%
Return on Assets
Net income ÷ assets
0x
Debt-to-Equity
Total liabilities ÷ equity

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $92.46M Mar 2, 2026
FY2025 Dec 31, 2024 $22.38M Mar 2, 2026
FY2025 Dec 31, 2023 ($151.71M) Mar 2, 2026
FY2024 Dec 31, 2022 $551.79M Feb 26, 2025
FY2023 Dec 31, 2021 $658.56M Feb 23, 2024
FY2022 Dec 31, 2020 ($128.41M) Feb 24, 2023
FY2021 Dec 31, 2019 $205.96M Feb 25, 2022
FY2020 Dec 31, 2018 ($290.39M) Feb 26, 2021
FY2019 Dec 31, 2017 $71.19M Feb 28, 2020
FY2018 Dec 31, 2016 $365.97M Feb 28, 2019

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $41.35M Mar 2, 2026
FY2025 Dec 31, 2024 $69.10M Mar 2, 2026
FY2025 Dec 31, 2023 $90.20M Mar 2, 2026
FY2024 Dec 31, 2022 $19.36M Feb 26, 2025
FY2023 Dec 31, 2021 ($19.07M) Feb 23, 2024
FY2022 Dec 31, 2020 ($2.16M) Feb 24, 2023
FY2021 Dec 31, 2019 $22.27M Feb 25, 2022
FY2020 Dec 31, 2018 $25.05M Feb 26, 2021
FY2019 Dec 31, 2017 ($1.46M) Feb 28, 2020
FY2018 Dec 31, 2016 ($13.57M) Feb 28, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $141.90M Mar 2, 2026
FY2025 Dec 31, 2024 $431.54M Mar 2, 2026
FY2025 Dec 31, 2023 $809.10M Mar 2, 2026
FY2024 Dec 31, 2022 $536.49M Feb 26, 2025
FY2023 Dec 31, 2021 ($637.20M) Feb 23, 2024
FY2022 Dec 31, 2020 ($33.53M) Feb 24, 2023
FY2021 Dec 31, 2019 $728.84M Feb 25, 2022
FY2020 Dec 31, 2018 ($45.39M) Feb 26, 2021
FY2019 Dec 31, 2017 $427.10M Feb 28, 2020
FY2018 Dec 31, 2016 ($291.35M) Feb 28, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.23B Mar 2, 2026
FY2025 Dec 31, 2024 $1.29B Mar 2, 2026
FY2024 Dec 31, 2023 $1.70B Feb 26, 2025
FY2023 Dec 31, 2022 $2.73B Feb 23, 2024
FY2022 Dec 31, 2021 $2.67B Feb 24, 2023
FY2021 Dec 31, 2020 $1.34B Feb 25, 2022
FY2020 Dec 31, 2019 $1.44B Feb 26, 2021
FY2019 Dec 31, 2018 $2.01B Feb 28, 2020
FY2018 Dec 31, 2017 $2.26B Feb 28, 2019
FY2017 Dec 31, 2016 $2.56B Feb 28, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.32M Mar 2, 2026
FY2025 Dec 31, 2024 $7.62M Mar 2, 2026
FY2024 Dec 31, 2023 $17.72M Feb 26, 2025
FY2023 Dec 31, 2022 $94.49M Feb 23, 2024
FY2022 Dec 31, 2021 $35.55M Feb 24, 2023
FY2021 Dec 31, 2020 $828.0K Feb 25, 2022
FY2020 Dec 31, 2019 $11.51M Feb 26, 2021
FY2019 Dec 31, 2018 $77.22M Feb 28, 2020
FY2018 Dec 31, 2017 $1.59M Feb 28, 2019
FY2017 Dec 31, 2016 $1.78M Feb 28, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.22B Mar 2, 2026
FY2025 Dec 31, 2024 $1.28B Mar 2, 2026
FY2025 Dec 31, 2023 $1.68B Mar 2, 2026
FY2025 Dec 31, 2022 $2.64B Mar 2, 2026
FY2024 Dec 31, 2021 $2.63B Feb 26, 2025
FY2023 Dec 31, 2020 $1.34B Feb 23, 2024
FY2022 Dec 31, 2019 $1.43B Feb 24, 2023
FY2021 Dec 31, 2018 $1.93B Feb 25, 2022
FY2020 Dec 31, 2017 $2.26B Feb 26, 2021
FY2019 Dec 31, 2016 $2.56B Feb 28, 2020

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2015 Dec 31, 2015 $92.09M Feb 29, 2016
FY2015 Dec 31, 2014 $745.59M Feb 29, 2016
FY2015 Dec 31, 2013 $123.07M Feb 29, 2016
FY2015 Dec 31, 2012 $615.72M Feb 29, 2016
FY2014 Dec 31, 2011 $542.29M Mar 2, 2015
FY2013 Jan 1, 2011 $51.93M Mar 3, 2014
FY2012 Dec 31, 2010 $51.93M Feb 22, 2013
FY2012 Dec 31, 2009 $243.81M Feb 22, 2013
FY2011 Dec 31, 2008 $1.71B Feb 28, 2012

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2016 Dec 31, 2016 2 Mar 1, 2017
FY2015 Dec 31, 2015 (1) Feb 29, 2016
FY2015 Sep 30, 2015 (2) Feb 29, 2016
FY2015 Jun 30, 2015 0 Feb 29, 2016
FY2015 Mar 31, 2015 (1) Feb 29, 2016
FY2015 Dec 31, 2014 (4) Feb 29, 2016
FY2015 Sep 30, 2014 (3) Feb 29, 2016
FY2015 Jun 30, 2014 0 Feb 29, 2016
FY2015 Mar 31, 2014 0 Feb 29, 2016
FY2014 Dec 31, 2013 0 Mar 2, 2015